PharmiWeb.com - Global Pharma News & Resources

AdoRx Therapeutics

Research & Development

AdoRx Therapeutics is a UK-based drug discovery company and backed by investment from Epidarex Capital and Sixth Element Capital. AdoRx Therapeutics is pursuing the discovery of new therapeutics for cancer-based on modulation of the adenosine pathway. High levels of adenosine in the tumour microenvironment enable cancer to evade the immune system.